APA (7th ed.) Citation

Yu, S., Yu, M., Keane, B., Mauro, D. M., Helft, P. R., Harris, W. P., . . . Somasundaram, A. (2024). A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma. The oncologist (Dayton, Ohio), 29(3), 270-e413. https://doi.org/10.1093/oncolo/oyad331

Chicago Style (17th ed.) Citation

Yu, Shawn, et al. "A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma." The Oncologist (Dayton, Ohio) 29, no. 3 (2024): 270-e413. https://doi.org/10.1093/oncolo/oyad331.

MLA (9th ed.) Citation

Yu, Shawn, et al. "A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma." The Oncologist (Dayton, Ohio), vol. 29, no. 3, 2024, pp. 270-e413, https://doi.org/10.1093/oncolo/oyad331.